Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse in Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01081769
What this trial is testing

Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 769
Post-approval studies (Phase 4)Ended earlyNCT05662306
What this trial is testing

C-Cog in Early Course Schizophrenia Study

Who this might be right for
Schizophrenia
University of Miami 1
Not applicableStudy completedNCT01952041
What this trial is testing

A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Dartmouth-Hitchcock Medical Center 149
Not applicableStudy completedNCT02220504
What this trial is testing

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Who this might be right for
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Fundación Marques de Valdecilla 68
Post-approval studies (Phase 4)Ended earlyNCT01576640
What this trial is testing

Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia

Who this might be right for
Nicotine DependenceSchizophrenia
Massachusetts General Hospital 17
Post-approval studies (Phase 4)Study completedNCT00253110
What this trial is testing

A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 396
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Not applicableStudy completedNCT00246194
What this trial is testing

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

Who this might be right for
Schizophrenia
Janssen, LP 532
Not applicableUnknownNCT00192751
What this trial is testing

From Compliance to Alliance: Engaging Psychiatric Patients in Illness Management

Who this might be right for
Patients Diagnosed With Severe Mental Illness
Rambam Health Care Campus 150
Large-scale testing (Phase 3)Study completedNCT01412060
What this trial is testing

Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 765
Large-scale testing (Phase 3)Looking for participantsNCT07227818
What this trial is testing

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Who this might be right for
Schizophrenia
Neurocrine Biosciences 560
Not applicableUnknownNCT01885923
What this trial is testing

A RCT Study in Schizophrenia Relapse Prevention

Who this might be right for
Relapse Schizophrenia
Prague Psychiatric Center 150
Not applicableNot Yet RecruitingNCT05839613
What this trial is testing

PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia

Who this might be right for
Patients With Schizophrenia
Assistance Publique Hopitaux De Marseille 400
Post-approval studies (Phase 4)UnknownNCT02210962
What this trial is testing

Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia

Who this might be right for
Schizophrenia
Medical University of Lodz 80
Large-scale testing (Phase 3)Study completedNCT00216476
What this trial is testing

Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag International NV 753
Large-scale testing (Phase 3)Looking for participantsNCT07565428
What this trial is testing

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

Who this might be right for
Negative Symptoms of Schizophrenia
Minerva Neurosciences 380
Not applicableLooking for participantsNCT07397975
What this trial is testing

Speech-based Assessment of Relapse Risk in People With Psychosis

Who this might be right for
Psychotic Disorder
Philipp Homan 360
Large-scale testing (Phase 3)Study completedNCT00143351
What this trial is testing

Mozart Relapse Study

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 75
Not applicableStudy completedNCT00712660
What this trial is testing

Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia

Who this might be right for
Schizophrenia
Prague Psychiatric Center 146
Not applicableUnknownNCT03090490
What this trial is testing

10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Who this might be right for
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Fundación Marques de Valdecilla 68
Next Page